These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11484719)
21. [Thiazolidindiones in type II diabetes mellitus]. Bornkessel B Med Monatsschr Pharm; 1998 Mar; 21(3):66-8. PubMed ID: 9556974 [No Abstract] [Full Text] [Related]
22. Warner Lambert/Sankyo diabetes drug nears market. Nat Biotechnol; 1997 Feb; 15(2):113. PubMed ID: 9035120 [No Abstract] [Full Text] [Related]
23. Hepatic injury due to troglitazone. Malik AH; Prasad P; Saboorian MH; Thiele DL; Malet PF Dig Dis Sci; 2000 Jan; 45(1):210-4. PubMed ID: 10695637 [No Abstract] [Full Text] [Related]
25. The rise and fall of troglitazone. Bailey CJ Diabet Med; 2000 Jun; 17(6):414-5. PubMed ID: 10975209 [No Abstract] [Full Text] [Related]
26. FDA reviews troglitazone. Donnelly R Diabetes Obes Metab; 1999 Mar; 1(2):65-6. PubMed ID: 11220513 [No Abstract] [Full Text] [Related]
27. [Type 2 diabetes. A new kind of insulin sensitizer at the door]. Böhm S MMW Fortschr Med; 1999 Jul; 141(27):56-7. PubMed ID: 10904588 [No Abstract] [Full Text] [Related]
28. Pulmonary edema associated with troglitazone therapy. Hirsch IB; Kelly J; Cooper S Arch Intern Med; 1999 Aug 9-23; 159(15):1811. PubMed ID: 10448787 [No Abstract] [Full Text] [Related]
29. A miracle of salamization: positive divided by two equals negative. Iwamoto Y Diabet Med; 1997 Nov; 14(11):994. PubMed ID: 9400931 [No Abstract] [Full Text] [Related]
30. Managing type 2 diabetes. A look at the newer agents. Larmore SS JAAPA; 1999 Jun; 12(6):47-8, 51-4, 57. PubMed ID: 10728087 [No Abstract] [Full Text] [Related]
31. Deterioration of rheumatoid arthritis with troglitazone: a rare and unexpected adverse effect. Sakurai A; Hashizume K Arch Intern Med; 2000 Jan; 160(1):118-9. PubMed ID: 10632316 [No Abstract] [Full Text] [Related]
32. Conversion from troglitazone to rosiglitazone. Bell DS; Ovalle F; Shadmany S Endocr Pract; 2001; 7(4):326. PubMed ID: 11497487 [No Abstract] [Full Text] [Related]
34. The chase is on (and I'm mad as hell). Ponte CD J Am Pharm Assoc (Wash); 2000; 40(4):466. PubMed ID: 10932454 [No Abstract] [Full Text] [Related]
35. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials. Krentz AJ; Bailey CJ; Melander A BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108 [No Abstract] [Full Text] [Related]
37. Pioglitazone and rosiglitazone for diabetes. Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802 [TBL] [Abstract][Full Text] [Related]
38. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones]. Lotz N MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793 [No Abstract] [Full Text] [Related]
39. Accelerated hypertension due to rosiglitazone therapy. Vikram NK; Misra A; Devi JR Indian Heart J; 2002; 54(6):733. PubMed ID: 12674195 [No Abstract] [Full Text] [Related]
40. Plaintiff's attorney actively seeking out patients who have used various FDA approved medications and who "may be entitled to compensation for damages caused by these medications". South D J Miss State Med Assoc; 2000 Nov; 41(11):798-9. PubMed ID: 11107716 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]